Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |